Keywords: HMSA; Potential stabilizer; Enhancement effect; NPF; Organosulfur chemistry;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: CD; Immunogenicity; Monitoring Therapy; Ulcerative Colitis; ATI; antibodies to infliximab; CD; Crohn's disease; CI; confidence interval; ELISA; enzyme-linked immunosorbent assay; HMSA; homogeneous mobility shift assay; HR; hazard ratio; IBD; inflammator
Keywords: TPP; therapeutic protein product; ADA; anti-drug antibody; mAb; monoclonal antibody; RA; rheumatoid arthritis; MS; multiple sclerosis; IBD; inflammatory bowel disease; NAb; neutralizing ADA; non-NAb; non-neutralizing ADA; PK; pharmacokinetics; PRCA; pure
American Gastroenterological Association Institute Technical Review on the Role of Therapeutic Drug Monitoring in the Management of Inflammatory Bowel Diseases
Keywords: ADAb; anti-drug antibody; AGA; American Gastroenterological Association; AZA; azathioprine; CBC; complete blood count; CD; Crohn's disease; CI; confidence interval; CRP; C-reactive protein; ECLIA; electrochemiluminescence immunoassay; ELISA; enzyme-link
Effects of Combination Therapy With Immunomodulators on Trough Levels and Antibodies Against Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Disease: AÂ Meta-analysis
Keywords: Crohn's Disease; Biologics; Pharmacokinetics; Serum Drug Level; ADA; antidrug antibodies; CD; Crohn's disease; CI; confidence interval; CZP; certolizumab pegol; ELISA; enzyme-linked immunosorbent assay; HMSA; homogenous mobility shift assay; IBD; infl
Standardization of the homogeneous mobility shift assay protocol for evaluation of anti-infliximab antibodies. Application of the method to Crohn's disease patients treated with infliximab
Keywords: Infliximab; Anti-drug antibodies; Crohn's disease; HMSA;
Monitoring of adalimumab and antibodies-to-adalimumab levels in patient serum by the homogeneous mobility shift assay
Keywords: ATA; antibodies-to-adalimumab; CD; Crohn's disease; HMSA; homogenous mobility shift assay; IBD; inflammatory bowel disease; PS; psoriasis; RA; rheumatoid arthritis; TNF-α; tumor necrosis factor-alpha; UC; ulcerative colitis; Adalimumab; Anti-drug antibod